PureTech Health PLC is a biotherapeutics company that focuses on the clinical development of therapies for severe diseases, including immunological, fibrotic, and inflammatory conditions. The company operates a hub-and-spoke model, advancing programs through Founded Entities, which are companies it has established to develop specific therapeutic candidates. PureTech generates revenue through equity interests and potential milestone payments from these entities, while also attracting external capital to support its initiatives. It operates primarily in the biotechnology sector, with a presence in Boston and the UK.